Goldman Sachs maintained its Buy recommendation on Bath & Body Works, Inc. (NYSE:BBWI) shares and reduced its price objective from $44 to $43.
A female customer browsing a variety of body care products in a retail store.
Bath & Body Works, Inc.’s strong first-quarter results were probably overshadowed by guidance that fell short of expectations. However, the analyst informs investors in a research note that today’s 6% stock price loss “seems overdone” because the firm’s FY25 EPS forecast is only declining by roughly 3%.
The Ohio-based business profited from U.S. sourcing, with only 10% of items coming from China and 7% from Canada and Mexico, reducing exposure to tariffs amid President Trump’s continued trade uncertainty.
Bath & Body Works, Inc.’s CFO Eva Boratto noted the company’s innovative products, such as Easter-themed candles, its robust domestic supply chain, and its ability to appeal to younger consumers through gift packaging and promotions.
READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.
Disclosure. None.
